ASEP — Asep Medical Holdings Cashflow Statement
0.000.00%
- CA$5.56m
- CA$14.91m
- CA$0.02m
Annual cashflow statement for Asep Medical Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -2.34 | -5.76 | -9.43 |
Depreciation | |||
Deferred Taxes | |||
Non-Cash Items | 1.3 | 1.37 | 3.77 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | -0.32 | -0.42 | 1.65 |
Change in Accounts Receivable | |||
Change in Prepaid Expenses | |||
Change in Payable / Accrued Expenses | |||
Change in Other Liabilities | |||
Cash from Operating Activities | -1.19 | -3.61 | -2.71 |
Capital Expenditures | -0.116 | 0 | -0.001 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 0.262 | 0.125 | -0.003 |
Sale of Business | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 0.146 | 0.125 | -0.004 |
Financing Cash Flow Items | -0.061 | 0 | -0.016 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 6.34 | 0.33 | 0.651 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 5.29 | -3.16 | -2.07 |